AI Engines For more Details: Perplexityβ Kagi Labsβ Youβ
Gut Health: Like other lactic acid bacteria, Pediococcus acidilactici may contribute to gut health by promoting a balanced gut microbiota. It can produce lactic acid, which helps maintain an acidic environment in the gut and inhibit the growth of pathogenic bacteria. Additionally, P. acidilactici may help improve digestion and nutrient absorption.
Immune Function: Some research suggests that Pediococcus acidilactici may have immunomodulatory effects and could help enhance immune function. It may stimulate the production of certain immune cells and cytokines, promoting a balanced immune response and reducing the risk of infections and inflammatory conditions.
Antimicrobial Activity: Pediococcus acidilactici produces antimicrobial substances such as bacteriocins, which have antibacterial properties. These substances may help inhibit the growth of harmful bacteria in the gut and other parts of the body, reducing the risk of infections.
Dairy Fermentation: Pediococcus acidilactici is commonly used in the fermentation of dairy products such as cheese and yogurt. Its presence in fermented foods contributes to their flavor, texture, and shelf life.
Animal Health: Pediococcus acidilactici is also used as a probiotic in animal feed to promote gut health and improve growth performance in livestock and poultry. It can help prevent gastrointestinal disorders and reduce the use of antibiotics in animal farming.
Potential Risks: While Pediococcus acidilactici is generally considered safe, there may be potential risks associated with its use, especially in individuals with compromised immune systems or underlying health conditions. As with any probiotic supplement, it's important to use caution and consult with a healthcare professional before incorporating it into your routine.
Rank | Probiotic | Impact |
---|---|---|
genus | Bacillus | Reduces |
genus | Bifidobacterium | Increases |
species | Bacillus aeolius | Reduces |
species | Bacillus horti | Reduces |
species | Bacillus infernus | Reduces |
species | Bacillus pumilus | Reduces |
species | Bacillus thermotolerans | Reduces |
species | Bacillus thuringiensis | Reduces |
species | Bacteroides uniformis | Reduces |
species | Bifidobacterium adolescentis | Increases |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
π Direct Citations | πͺπΆ Indirect Citations | Taxonomy | Rank | Effect |
---|---|---|---|---|
5 | 0 | Bifidobacterium | genus | Increases |
3 | 0 | Lactobacillus | genus | Increases |
3 | 0 | Roseburia | genus | Increases |
2 | 2 | Enterobacteriaceae | family | Decreases |
2 | 1 | Blautia | genus | Increases |
2 | 1 | Faecalibacterium | genus | Increases |
2 | 0 | Ruminococcus | genus | Increases |
2 | 0 | Bacillota | phylum | Increases |
2 | 0 | Bacillus cereus | species | Decreases |
2 | 0 | Listeria monocytogenes | species | Decreases |
2 | 0 | Staphylococcus aureus | species | Decreases |
1 | 3 | Oscillospiraceae | family | Increases |
1 | 3 | Lachnospiraceae | family | Increases |
1 | 3 | Escherichia | genus | Decreases |
1 | 3 | Salmonella | genus | Decreases |
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive β X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Abdominal Aortic Aneurysm | 0.6 | 0.6 | 0 |
Acne | 5.9 | 1.1 | 4.36 |
ADHD | 7.1 | 7.2 | -0.01 |
Age-Related Macular Degeneration and Glaucoma | 0.6 | 0.9 | -0.5 |
Allergic Rhinitis (Hay Fever) | 7.2 | 5 | 0.44 |
Allergies | 11.7 | 10.1 | 0.16 |
Allergy to milk products | 4.2 | 5 | -0.19 |
Alopecia (Hair Loss) | 2.5 | 3.6 | -0.44 |
Alzheimer's disease | 18.1 | 9.6 | 0.89 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 4.3 | 6.5 | -0.51 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. β Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA β Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. β Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. β Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.217 ]